Search Results 431-440 of 17192 for egfr

1. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure - Mayo Clinic

   Clinically significant intrinsic renal disease (eGFR <15 ml/min/1.72m2), renal artery stenosis, or history of fibromuscular dysplasia of the renal arteries.

2. Dual-Hormone Control of Post-absorptive and Post-prandial Glucose in Type 1 Diabetes - Mayo Clinic

   Creatinine ≤ 1.5 mg/dl or eGFR of >50 ml/min; no acute or chronic disease; current non-smoker; alcohol consumption <5 g/week; for women of child bearing ...

3. Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Mayo Clinic

   Serum creatinine > 1.5 x ULN or eGFR 160 mmHg and/or diastolic blood pressure > 95 mmHg). Baseline standard 12-lead ECG that demonstrates clinically ...

4. Electrocardiogram (ECG Or EKG) Clinical Trials - Mayo Clinic Research

   Ambulatory adult patients at increased risk for hyperkalemia due to age ≥ 50 years, and one or more criteria including eGFR (from serum creatinine) < 45 ...

5. A Study to Evaluate Endometriosis with PET/MRI - Mayo Clinic

   Unable to receive IV Gadolinium contrast for any reason (renal failure eGFR < 60, contrast allergy); Pregnant. Participating Mayo Clinic locations. Study ...

6. Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics - Mayo Clinic

   Estimated glomerular filtration rate (eGFR by CKD-Epi) \<60 ml/min/1.73 m2 or Cr \>2.0 mg/dL. 5. Uncontrolled hepatic encephalopathy requiring 2 or more ...

7. Clinical Impact of Cardiac Photon Counting CT

   - eGFR ≤ 30 - History of prior moderate or severe contrast reaction includes: unresponsiveness, severe respiratory distress, convulsions, arrhythmia ...

8. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) at screening ≥ 30 mL/min normalized to 1.73 m2 BSA calculated using Chronic Kidney Disease Epidemiology ...

9. A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

   if RAS wild-type, an anti-EGFR therapy (e.g., cetuximab, panitumumab);. Subjects with microsatellite-high (MSI-H) or mismatch repair deficient (dMMR) tumors ...

10. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) - Mayo Clinic

    * Estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m\^2 * Liver failure * Uncontrolled blood pressure * Unable or unwilling to take vitamin A ...